Management of autoimmune disease–associated ILD may involve immunosuppressant and/or antifibrotic therapy in addition to supportive care. It is important that treatment decisions be ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Interstitial Lung Diseases Pipeline Outlook DWN12088 is an investigational ... LYT-100 is being advanced for the potential ...

With ILD, the interstitium becomes stiff and thick, making it harder to move air in and out of your lungs. Classifying ILDs helps healthcare providers identify the cause and determine the most ...

The effects of ILD are chronic and permanent. It cannot be reversed and may potentially develop further over time if regular ...

The experts of the Interstitial Lung Disease program collaborate with a multispecialty team, providing comprehensive care to patients who have multiple needs. Our collaborative nature ensures you have ...

Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD ...

"If you look at ILD and PE outcomes ... whereas a PE in fibrotic tissue may be clinically insignificant and not require treatment. "So it goes both ways: You don't overtreat and you don't ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

The toxin strychnine, the primary component of the traditional Chinese medicine, may act in the STAT3 pathway, investigators ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...

Interstitial lung disease (ILD), a condition characterized by inflammation and fibrosis, is a major cause of severe respiratory illness ... In a head-to-head study, FAPI PET/CT was found to be ...